Previously, there was a study showing that adiposity significantly increases the effect of the three variants (PNPLA3-I148M, TM6SF2-E167K, and GCKR-P446L) associated with nonalcoholic fatty liver disease (NAFLD). Here, GCKR is linked to metabolic dysfunction-associated steatotic liver disease.